TRIPODO, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 24.833
EU - Europa 10.812
AS - Asia 9.289
SA - Sud America 1.822
AF - Africa 307
OC - Oceania 80
Continente sconosciuto - Info sul continente non disponibili 10
Totale 47.153
Nazione #
US - Stati Uniti d'America 24.528
SG - Singapore 3.509
RU - Federazione Russa 2.627
IT - Italia 2.609
CN - Cina 2.305
BR - Brasile 1.428
FI - Finlandia 1.137
HK - Hong Kong 991
DE - Germania 910
VN - Vietnam 885
UA - Ucraina 679
PL - Polonia 666
GB - Regno Unito 530
IE - Irlanda 495
FR - Francia 423
JP - Giappone 337
BD - Bangladesh 234
SE - Svezia 212
KR - Corea 193
IN - India 190
AR - Argentina 147
NL - Olanda 138
CA - Canada 137
TR - Turchia 102
CI - Costa d'Avorio 100
MX - Messico 99
IQ - Iraq 89
AT - Austria 82
AU - Australia 75
ES - Italia 58
RO - Romania 54
ID - Indonesia 52
BE - Belgio 50
EC - Ecuador 49
VE - Venezuela 49
ZA - Sudafrica 49
PK - Pakistan 45
UZ - Uzbekistan 44
MA - Marocco 37
IR - Iran 33
PY - Paraguay 32
SA - Arabia Saudita 32
CO - Colombia 31
CH - Svizzera 28
EG - Egitto 28
KE - Kenya 28
CL - Cile 26
MY - Malesia 26
PH - Filippine 26
NP - Nepal 25
UY - Uruguay 23
PE - Perù 20
AE - Emirati Arabi Uniti 19
JM - Giamaica 18
KZ - Kazakistan 18
DZ - Algeria 17
GR - Grecia 17
JO - Giordania 16
TN - Tunisia 15
BO - Bolivia 14
TW - Taiwan 14
CZ - Repubblica Ceca 13
CR - Costa Rica 12
DO - Repubblica Dominicana 12
LT - Lituania 12
AZ - Azerbaigian 11
BG - Bulgaria 10
LB - Libano 10
KG - Kirghizistan 9
OM - Oman 8
RS - Serbia 8
AL - Albania 7
BH - Bahrain 7
GE - Georgia 7
IL - Israele 7
LK - Sri Lanka 7
LV - Lettonia 7
SN - Senegal 7
DK - Danimarca 6
MD - Moldavia 6
PA - Panama 6
PT - Portogallo 6
SY - Repubblica araba siriana 6
TH - Thailandia 6
BA - Bosnia-Erzegovina 5
BY - Bielorussia 5
ET - Etiopia 5
EU - Europa 5
QA - Qatar 5
TT - Trinidad e Tobago 5
EE - Estonia 4
HN - Honduras 4
KH - Cambogia 4
MN - Mongolia 4
BN - Brunei Darussalam 3
GT - Guatemala 3
HU - Ungheria 3
NG - Nigeria 3
PS - Palestinian Territory 3
XK - ???statistics.table.value.countryCode.XK??? 3
Totale 47.104
Città #
Fairfield 3.232
Ashburn 3.045
Singapore 2.369
Woodbridge 1.575
Seattle 1.281
Houston 1.279
Wilmington 1.265
Cambridge 1.187
San Jose 1.110
Chandler 1.108
Hong Kong 948
Ann Arbor 681
Zgierz 603
Dublin 494
Moscow 455
Medford 426
Council Bluffs 407
Helsinki 385
Beijing 384
Jacksonville 367
Santa Clara 360
Palermo 348
Des Moines 347
Altamura 318
Tokyo 313
Los Angeles 281
Ho Chi Minh City 280
Lauterbourg 267
Dallas 265
Princeton 262
Lawrence 243
Nanjing 236
San Diego 228
Frankfurt am Main 216
Hanoi 207
New York 201
Hefei 181
Dearborn 172
Milan 169
Boardman 151
São Paulo 138
Chicago 130
London 125
Rome 119
Buffalo 117
Nuremberg 102
Tulsa 101
Abidjan 100
Ludwigshafen am Rhein 97
Phoenix 88
Nanchang 73
Changsha 69
Hebei 68
The Dalles 66
Shenyang 64
Orem 62
Jinan 56
San Paolo di Civitate 56
Tianjin 53
Da Nang 51
Bremen 50
Atlanta 49
Lappeenranta 48
Seongnam 48
Zhengzhou 44
Shanghai 43
Brighton 42
Brussels 42
Columbus 42
Falls Church 42
Jiaxing 40
Saint Petersburg 39
Trieste 39
Denver 38
Amsterdam 36
Boston 35
Chennai 35
Izmir 34
Munich 34
Rio de Janeiro 34
Tashkent 34
Warsaw 34
Washington 34
Guangzhou 33
Montreal 33
Poplar 32
Verona 32
Vienna 32
Naples 30
Belo Horizonte 29
Brasília 29
Ningbo 29
Kumar 28
Kilburn 27
Manchester 27
Stockholm 27
Brooklyn 26
Toronto 26
Dhaka 25
Haiphong 25
Totale 30.787
Nome #
Mast cells contribute to autoimmune diabetes by releasing interleukin-6 and failing to acquire a tolerogenic IL-10(+) phenotype 843
ITTERO OSTRUTTIVO COME SINTOMO DI ESORDIO IN SOGGETTO CON LEUCEMIA MONOCITICA ACUTA. CASO CLINICO 354
Pathobiology of Hodgkin lymphoma. 331
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4 326
A complex case of fatal calciphylaxis in a female patient with hyperparathyroidism secondary to end stage renal disease of graft and coexistence of haemolytic uremic syndrome 325
Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8 313
Carbamazepine transbuccal delivery: the histo-morphological features of reconstituted human oral epithelium and buccal porcine mucosae in the transmucosal permeation 308
Associations between Notch-2, Akt-1 and HER2/neu expression in invasive human breast cancer: a tissue microarray immunophenotypic analysis on 98 patients. 299
BIOCOMPATIBILITY AND BIODEGRADABILITY OF ELECTROSPUN PHEA-PLA SCAFFOLDS: OUR PRELIMINARY EXPERIENCE IN A MURINE ANIMAL MODEL 298
CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis 292
Microenvironment-centred dynamics in aggressive B-cell lymphomas. 289
C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation 284
CD4+CD25+ Regulatory T Cells Suppress Mast Cell Degranulation and Allergic Responses through OX40-OX40L Interaction 278
Splenic marginal zone lymphoma with or without villous lymphocytes 269
An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development. 260
C1q induces in vivo angiogenesis and promotes wound healing 259
The Hepatic Expression of Vitamin D Receptor is Inversely Associated with the Severity of Liver Damage in Genotype 1 Chronic Hepatitis C Patients. 250
Assessment of the frequency of additional cancers in patients with splenic marginal zone lymphoma. 249
Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma 249
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. 248
High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis 245
Mast Cells and Th17 Cells Contribute to the Lymphoma-Associated Pro-Inflammatory Microenvironment of Angioimmunoblastic T-Cell Lymphoma 244
IFI16 expression is related to selected transcription factors during B-cell differentiation 244
Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection 242
Sistemic calciphylaxis and thrombotic microangiopathy in a kidney transplant patient: two mixing fatal syndromes? 242
MERTK rs4374383 polymorphism affects the severity of fibrosis in nonalcoholic fatty liver disease 238
Assessment of the Frequency of Additional Malignancies in Patients with Splenic Marginal Zone Lymphoma 237
A ceRNA approach may unveil unexpected contributors to deletion syndromes, the model of 5q- syndrome 237
COVID-19 Vaccine and Death: Causality Algorithm According to the WHO Eligibility Diagnosis 236
C1q Production by Bone Marrow Stromal Cells 234
Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression 234
Release of naltrexone on buccal mucosa: permeation studies, histological aspects and matrix system design 233
Splenic marginal zone lymphoma: a prognostic model for clinical use. 232
C1q as a unique player in angiogenesis with therapeutic implication in wound healing 231
Correlation between expression of cyclooxygenase-2 and the presence of inflammatory cells in human primary hepatocellular carcinoma: possible role in tumor promotion and angiogenesis. 230
T Cell Large Granular Lymphocytic Leukemia in Association with Sjógren's Syndrome 228
An automated image analysis methodology for classifying megakaryocytes in chronic myeloproliferative disorders 228
Angioimmunoblastic T-cell lymphoma 225
Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis 224
Assessment of the Frequency of Additional Malignancies in Patients with Splenic Marginal Zone Lymphoma (SMZL) 220
A non-redundant role for OX40 in the competitive fitness of Treg in response to IL-2. 220
Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphoma 220
The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway. 220
Antibody-mediated blockade of JMJD6 interaction with collagen I exerts antifibrotic and antimetastatic activities 220
CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. 218
The bone marrow stroma in hematological neoplasms-a guilty bystander. 218
Constant detection of cyclooxygenase 2 in terminal stages of myeloid maturation. 216
Different immunophenotypical apoptotic profiles characterise megakaryocytes of essential thrombocythaemia and primary myelofibrosis. 215
Predictive role of histological features and Ki67 pattern on high-risk HPV presence in atypical cervical lesions. 214
Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity 213
Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolence 210
Iron capture through CD71 drives perinatal and tumor-associated Treg expansion 209
Immunophenotypic profile and role of adhesion molecules in splenic marginal zone lymphoma with bone marrow involvement 209
The aryl hydrocarbon receptor modulates acute and late mast cell responses. 207
Use of intrapleural bortezomib in myelomatous pleural effusion [1] 205
Mast cells infiltrating inflamed or transformed gut alternatively sustain mucosal healing or tumor growth 200
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome. 199
Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion. 199
Real-time detection of BRAF V600E mutation from archival hairy cell leukemia FFPE tissue by nanopore sequencing 198
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study 198
Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: A Fondazione Italiana Linfomi phase II study 198
Histological features and ki-67 Index in cervical atypical lesions 197
Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C 194
Osteopontin shapes immunosuppression in the metastatic niche 193
RORC1 Regulates Tumor-Promoting "Emergency" Granulo-Monocytopoiesis 193
Progressive visceral leishmaniasis misdiagnosed as cirrhosis of the liver: a case report. 192
Long-lasting remission of primary hepatic lymphoma and hepatitis C virus infection achieved by the alpha-interferon treatment 191
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. 189
C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function 189
miR-9 and miR-200 regulate PDGFRβ-mediated endothelial differentiation of tumor cells in triple-negative breast cancer 189
Direct RNA Nanopore Sequencing of SARS-CoV-2 Extracted from Critical Material from Swabs 189
Deoxycoformycin (pentostatin) in the treatment of Splenic Marginal Zone Lymphoma (SMZL)with or without villous lymphocytes 188
Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate Cancer 187
Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers 186
Humoral immunotherapy of multiple myeloma: perspectives and perplexities 185
Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage hodgkin lymphoma in the pre-positron emission tomography era: A Gruppo Italiano Studio Linfomi (GISL) prospective trial 185
Oncogene-driven intrinsic inflammation induces leukocyte production of tumor necrosis factor that critically contributes to mammary carcinogenesis. 184
Dynamics of complement activation in aHUS and how to monitor eculizumab therapy. 184
SOCS2 controls proliferation and stemness of hematopoietic cells under stress conditions and its deregulation marks unfavorable acute leukemias 184
Complement protein C1q binds to hyaluronic acid in the malignant pleural mesothelioma microenvironment and promotes tumor growth 184
ATR expands embryonic stem cell fate potential in response to replication stress 183
Presenting features and outcome of Splenic Marginal Zone Lymphoma with or without villous lymphocytes. A retrospective analysis in a Series of 145 Patients 182
A novel role of the CX(3)CR1/CX(3)CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment. 182
MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases 182
PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cells 181
A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles 181
Antibody-Fc/FcR interaction on macrophages as a mechanism for hyperprogressive disease in non-small cell lung cancer subsequent to PD-1/PD-L1 blockade 181
Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces 181
Mast cells boost myeloid-derived suppressor cell activity and contribute to the development of tumor-favoring microenvironment 180
The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 179
Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer 178
Exploratory study on the effects of biodegradable nanoparticles with drugs on malignant B cells and on a human/mouse model of Burkitt lymphoma. 178
Stromal niche communalities underscore the contribution of the matricellular protein SPARC to B-cell development and lymphoid malignancies 178
TRABECTEDIN OVERRIDES OSTEOSARCOMA DIFFERENTIATIVE BLOCK AND REPROGRAMS THE TUMOR IMMUNE ENVIRONMENT ENABLING EFFECTIVE COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS 178
Breast cancer organoids model patient‐specific response to drug treatment 178
Common extracellular matrix regulation of myeloid cell activity in the bone marrow and tumor microenvironments 176
Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk 176
Transcriptional Profiles and Stromal Changes Reveal Bone Marrow Adaptation to Early Breast Cancer in Association with Deregulated Circulating microRNAs 176
Preeclampsia is associated with defective production of C1q by invasive trophoblast 175
Class IIa HDACs repressive activities on MEF2-depedent transcription are associated with poor prognosis of ER⁺ breast tumors. 174
Totale 22.576
Categoria #
all - tutte 179.950
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 179.950


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021360 0 0 0 0 0 0 0 0 0 0 0 360
2021/20223.547 206 633 166 107 141 170 263 194 374 424 283 586
2022/20233.986 372 854 66 345 408 550 339 276 428 44 213 91
2023/20241.980 73 302 147 165 148 384 234 127 43 98 38 221
2024/20255.042 222 429 400 394 182 168 352 309 402 565 537 1.082
2025/202617.753 1.133 545 1.232 1.610 1.618 2.315 2.351 1.714 1.487 2.042 1.546 160
Totale 48.961